Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 4.16 Bil PE Ratio: 0 PB Ratio: 11.95 GF Score: 61/100

Alpine Immune Sciences Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 05:00PM GMT
Release Date Price: $8.21 (-2.49%)
Tom Smith
SVB Securities LLC - Analyst

All right. Good afternoon, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at SVB and excited to welcome our next presenting company, Alpine Immune Sciences, and very happy to introduce Chief Business Officer. Remy Durand. Remy, thanks for joining us.

Remy Durand
Alpine Immune Sciences, Inc. - Chief Business Officer

Great. Thank you, Tom and SVB for the invitation to present here at the conference this year. And thank you to everyone listening in on the webcast. As Tom mentioned, my name is Remy Durand. And I lead investor relations, business development, and corporate strategy for Alpine Immune Sciences. Today, I'll be making forward-looking statements. Please consult our website for a full list of SEC filings.

At Alpine, we're leading the next evolution of immunotherapies for autoimmune disease and inflammatory disease with two compelling molecules, both developed from our highly productive directed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot